CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings

CPEX Pharmaceuticals, Inc. CPEX today announced that, based on the vote count certified by the independent inspector of election, IVS Associates, Inc., stockholders have approved the Company's proposed merger agreement with FCB I Holdings Inc. at the special meeting of stockholders held today.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&AHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!